@ImmunityAnd

A peer-reviewed, Medline-indexed open access journal providing rapid publication across the breadth of immunology research

Joined May 2019
  • Tweets26
  • Following7
  • Followers91
4Media
IID has received its impact factor! Impact factor: 2.5 2019 Journal Citation Reports (Clarivate Analytics): 112/158 (Immunology) Many thanks to all authors for the trust and reviewers for their vital work.
4
Immunity Inflammation and Disease journal retweeted
Département d'Anesthésie-Réanimation@DMU_DREAM13 Oct 2021
Nouvelle publication du Dr Stéphanie Pons sur la thématique de l'immunomodulation par les cellules endothéliales dans le cadre du sepsis. Bravo ! onlinelibrary.wiley.com/doi/… @ImmunityAnd @SFAR_ORG @La_SRLF @APHP
2
6
Immunity Inflammation and Disease journal retweeted
LIMES Institute Bonn@LIMES_Bonn3 Sep 2021
CCL17-expressing #dendritic #cells in the intestine are preferentially infected by #Salmonella but #CCL17 plays a redundant role in systemic dissemination @FoersterLab @UniBonn @ImmunityAnd bit.ly/3jFw24k
4
10
Immunity Inflammation and Disease journal retweeted
Nazlie Latefi PhD
@nlatefi22 Jun 2021
Our #research study published in @ImmunityAnd uncovered a #breakthrough in treating #respiratory #inflammation #sorethroat and found that common OTC drugs are causing more harm than good. businesswire.com/news/home/2…

Applied Bio Study Uncovers Major Breakthrough in Understanding and Treating Respiratory Inflammation

Applied Bio peer-reviewed study uncovered a breakthrough in treating respiratory inflammation; found common OTC drugs can cause more harm than good.

businesswire.com
1
1
Immunity Inflammation and Disease journal retweeted
EFIS@EFIS_Immunology20 May 2021
📢Thanks to @iuis_online for providing registration grants to attend the @2021ECI ! To be in with a chance of getting waived registration: 1. Submit an abstract by May 24 🔗buff.ly/3haoENs 2. Apply for a grant @EFIS_Immunology 🔗buff.ly/3byvGs4
1
12
11
Publishing #openaccess can broaden the impact of your work, but did you know you might be able to publish #OA in Immunity, Inflammation and Disease at no direct cost? Check to see if you’re eligible. secure.wiley.com/openaccess @wileyinresearch
1
Immunity Inflammation and Disease journal retweeted
Timothy Gottschalk@TimGottschalk14 May 2021
Check out our latest paper showing #GCSF is not pathogenic (and maybe protective?) in #lupus published in Immunity, Inflammation and Disease @ImmunityAnd doi.org/10.1002/iid3.430
2
2
Immunity Inflammation and Disease journal retweeted
LIMES Institute Bonn@LIMES_Bonn5 May 2021
Ahead of print: CCL17-expressing #dendritic cells in the #intestine are preferentially infected by #Salmonella but #CCL17 plays a redundant role in #systemic #dissemination @ImmunityAnd #FörsterLab @TheDohertyInst bit.ly/3eYTpCF

CCL17-expressing dendritic cells in the intestine are preferentially infected by Salmonella but...

CCL17-expressing DCs were preferentially infected by Salmonella in the intestine in comparison to other DC. Nevertheless, the production of CCL17 was not essential for the early dissemination of...

pubmed.ncbi.nlm.nih.gov
2
5
Immunity Inflammation and Disease journal retweeted
Wiley Life Sciences@WileyLifeSci23 Feb 2021
Now available: check out the March issue of the #OpenAccess journal Immunity, Inflammation and Disease: ow.ly/2EEx50DGsZa @ImmunityAnd
1
1
Remember as authors; choose your potential reviewer carefully: not your friends nor those that are unlikely to look at your manuscript. Add as many potential reviewers to Manuscript central. All scientists are busy and may not have time when you submit an manuscript.
1
1
Do review please. You may learn something new, ensure quality and robustness in your field. But be on time. Support your field. If nobody is willing to review, nothing will be published and the field will be poorer for it. Don´t expect others to do the reviewing, if you don´t.
1
Lots of authors are publishing #openaccess in Immunity, Inflammation and Disease at no direct cost. @wileyinresearch has #OA agreements with many countries and regions. Check to see if you're eligible. secure.wiley.com/openaccess
Publishing #openaccess can broaden the impact of your work, but did you know you might be able to publish #OA in Immunity, Inflammation and Disease at no direct cost? Check to see if you’re eligible. secure.wiley.com/openaccess @wileyinresearch
1
Good news! You may be able to publish #openaccess in Immunity, Inflammation and Disease at no direct cost. @wileyinresearch has agreements with many countries and regions. Check if you’re eligible. secure.wiley.com/openaccess
1
1
Excellent paper generating good interest: onlinelibrary.wiley.com/doi/… Check it out!
IL-6 signaling requires only few interleukin-6 molecules: Relation to physiological concentrations of extracellular IL-6. Understand what a given plasma concentration of a cytokine signifies. Out in IID soon! @Morten_Bagge
1
Excellent new paper accepted. In biopsies, upregulation of DNASE1L3 in asthma and IL1B in neutrophilic asthma similar to previously findings in sputum. Coming online soon on onlinelibrary.wiley.com/jour… @SSanchezOvando
1
3
Excellent issue number 3, September 2019, online now! onlinelibrary.wiley.com/toc/…
1
Load more